| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Beverly A Huss is Director at RBOT, with reported holdings spanning 4 companies. Beverly A Huss's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $154K at current prices.
Beverly A Huss's largest disclosed position is in IRIX as Director, worth about $64K. Net of sales, the IRIX filings show accumulation of 25,900 shares.
Beverly A Huss has 28 Form 4 filings on record from January 2018 to May 2026, across 4 companies: Director at InfuSystem (INFU), 2024–2026; Director at Accuray (ARAY), 2018–2025; Vicarious Surgical (RBOT), 2022–2025, and 1 more.
The 29 reported transactions were 12 stock awards, 7 option or other derivative awards, 7 tax withholdings and 2 open-market purchases, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 2 purchases worth about $61K and no sales.
The largest open-market purchase was 25,900 shares of IRIX at an average $1.22 on April 23, 2025, about $31K.